Search Results - Christina Yau

Refine Results
  1. 1
    Ageing, oxidative stress and cancer: paradigms in parallax

    Ageing, oxidative stress and cancer: paradigms in parallax by Christopher C. Benz, Christina Yau

    Published 2008
    Get full text
    Revisão
    Save to List
    Saved in:
  2. 2
    Gene Co-Expression Modules as Clinically Relevant Hallmarks of Breast Cancer Diversity

    Gene Co-Expression Modules as Clinically Relevant Hallmarks of Breast Cancer Diversity by Denise M. Wolf, Marc E. Lenburg, Christina Yau, Aaron Boudreau, Laura van ‘t Veer

    Published 2014
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  3. 3
    Clinically Meaningful Tumor Reduction Rates Vary by Prechemotherapy MRI Phenotype and Tumor Subtype in the I-SPY 1 TRIAL (CALGB 150007/150012; ACRIN 6657)

    Clinically Meaningful Tumor Reduction Rates Vary by Prechemotherapy MRI Phenotype and Tumor Subtype in the I-SPY 1 TRIAL (CALGB 150007/150012; ACRIN 6657) by Rita A. Mukhtar, Christina Yau, Mark Rosen, Vickram J. Tandon, Nola Hylton, Laura J. Esserman

    Published 2013
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  4. 4
    A multigene predictor of metastatic outcome in early stage hormone receptor-negative and triple-negative breast cancer

    A multigene predictor of metastatic outcome in early stage hormone receptor-negative and triple-negative breast cancer by Christina Yau, Laura J. Esserman, Dan H. Moore, Fred Waldman, John J. Sninsky, Christopher C. Benz

    Published 2010
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  5. 5
    Enhanced NFκB and AP-1 transcriptional activity associated with antiestrogen resistant breast cancer

    Enhanced NFκB and AP-1 transcriptional activity associated with antiestrogen resistant breast cancer by Yamei Zhou, Christina Yau, Joe W. Gray, Karen Chew, Shanaz H. Dairkee, Dan H. Moore, Urs Eppenberger, Serenella Eppenberger‐Castori, Christopher C. Benz

    Published 2007
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  6. 6
    Comprehensive transcriptomic analysis of cell lines as models of primary tumors across 22 tumor types

    Comprehensive transcriptomic analysis of cell lines as models of primary tumors across 22 tumor types by Katharine Yu, Bin Chen, Dvir Aran, Joseph K. Charalel, Christina Yau, Denise M. Wolf, Laura van ‘t Veer, Atul J. Butte, Theodore C. Goldstein, Marina Sirota

    Published 2019
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  7. 7
    Serial expression analysis of breast tumors during neoadjuvant chemotherapy reveals changes in cell cycle and immune pathways associated with recurrence and response

    Serial expression analysis of breast tumors during neoadjuvant chemotherapy reveals changes in cell cycle and immune pathways associated with recurrence and response by Mark Jesus M. Magbanua, Denise M. Wolf, Christina Yau, Sarah Davis, Julia Crothers, Alfred Au, Christopher M. Haqq, Chad Livasy, Hope S. Rugo, Laura J. Esserman, John W. Park, Laura van ’t Veer

    Published 2015
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  8. 8
    Use of Molecular Tools to Identify Patients With Indolent Breast Cancers With Ultralow Risk Over 2 Decades

    Use of Molecular Tools to Identify Patients With Indolent Breast Cancers With Ultralow Risk Over 2 Decades by Laura J. Esserman, Christina Yau, Carlie K. Thompson, Laura van ‘t Veer, Alexander D. Borowsky, Katherine A. Hoadley, Nicholas P. Tobin, Bo Nordenskjöld, Tommy� Fornander, Olle Stål, Christopher C. Benz, Linda S. Lindström

    Published 2017
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  9. 9
    Assessment of Long-term Distant Recurrence-Free Survival Associated With Tamoxifen Therapy in Postmenopausal Patients With Luminal A or Luminal B Breast Cancer

    Assessment of Long-term Distant Recurrence-Free Survival Associated With Tamoxifen Therapy in Postmenopausal Patients With Luminal A or Luminal B Breast Cancer by Nancy Yu, Adina Iftimi, Christina Yau, Nicholas P. Tobin, Laura van ‘t Veer, Katherine A. Hoadley, Christopher C. Benz, Bo Nordenskjöld, Tommy Förnander, Olle Stål, Kamila Czene, Laura J. Esserman, Linda S. Lindström

    Published 2019
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  10. 10
    RPL24: a potential therapeutic target whose depletion or acetylation inhibits polysome assembly and cancer cell growth

    RPL24: a potential therapeutic target whose depletion or acetylation inhibits polysome assembly and cancer cell growth by Kathleen A. Wilson-Edell, Amanuel Kehasse, Gary K. Scott, Christina Yau, Daniel E. Rothschild, Birgit Schilling, Bianca S. Gabriel, Mariya Yevtushenko, Ingrid M. Hanson, Jason M. Held, Bradford W. Gibson, Christopher C. Benz

    Published 2014
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  11. 11
    Aging impacts transcriptomes but not genomes of hormone-dependent breast cancers

    Aging impacts transcriptomes but not genomes of hormone-dependent breast cancers by Christina Yau, Vita Fedele, Ritu Roydasgupta, Jane Fridlyand, Alan Hubbard, Joe W. Gray, Karen Chew, Shanaz H. Dairkee, Dan H. Moore, Francesco Schittulli, Stefania Tommasi, Angelo Paradiso, Donna G. Albertson, Christopher C. Benz

    Published 2007
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  12. 12
    Ribavirin Treatment Effects on Breast Cancers Overexpressing eIF4E, a Biomarker with Prognostic Specificity for Luminal B-Type Breast Cancer

    Ribavirin Treatment Effects on Breast Cancers Overexpressing eIF4E, a Biomarker with Prognostic Specificity for Luminal B-Type Breast Cancer by Filippa Pettersson, Christina Yau, Monica C. Dobocan, Biljana Culjkovic‐Kraljacic, Hélène Retrouvay, Rachel Puckett, Ludmila M. Flores, Ian E. Krop, Caroline Rousseau, Eftihia Cocolakis, Katherine L. B. Borden, Christopher C. Benz, Wilson H. Miller

    Published 2011
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  13. 13
    Biologic markers determine both the risk and the timing of recurrence in breast cancer

    Biologic markers determine both the risk and the timing of recurrence in breast cancer by Laura J. Esserman, Dan H. Moore, Pamela Tsing, Philip Chu, Christina Yau, Elissa M. Ozanne, Robert Chung, Vickram J. Tandon, John W. Park, Frederick L. Baehner, Stig Kreps, Andrew Tutt, Cheryl Gillett, Christopher C. Benz

    Published 2011
    Get full text
    Artigo
    Save to List
    Saved in:
  14. 14
    Comparison of residual cancer burden, American Joint Committee on Cancer staging and pathologic complete response in breast cancer after neoadjuvant chemotherapy: results from the I-SPY 1 TRIAL (CALGB 150007/150012; ACRIN 6657)

    Comparison of residual cancer burden, American Joint Committee on Cancer staging and pathologic complete response in breast cancer after neoadjuvant chemotherapy: results from the... by Jeffrey I. Campbell, Christina Yau, Polina Krass, Dan H. Moore, Lisa A. Carey, Alfred Au, David C. Chhieng, Dilip D. Giri, Chad Livasy, Carolyn Mies, Joseph T. Rabban, Venetia Sarode, Baljit Singh, Laura J. Esserman, Yunn-Yi Chen

    Published 2017
    Get full text
    Artigo
    Save to List
    Saved in:
  15. 15
    Lobular histology and response to neoadjuvant chemotherapy in invasive breast cancer

    Lobular histology and response to neoadjuvant chemotherapy in invasive breast cancer by Esther H. Lips, Rita A. Mukhtar, Christina Yau, Jorma J. de Ronde, Chad Livasy, Lisa A. Carey, Claudette E. Loo, Marie-Jeanne T. F. D. Vrancken-Peeters, Gabe S. Sonke, Donald A. Berry, Laura J. vanʼt Veer, Laura J. Esserman, Jelle Wesseling, Sjoerd Rodenhuis, E. Shelley Hwang

    Published 2012
    Get full text
    Artigo
    Save to List
    Saved in:
  16. 16
    PIM1 kinase inhibition as a targeted therapy against triple-negative breast tumors with elevated MYC expression

    PIM1 kinase inhibition as a targeted therapy against triple-negative breast tumors with elevated MYC expression by Dai Horiuchi, Roman Camarda, Alicia Y. Zhou, Christina Yau, Olga Momčilović, Sanjeev Balakrishnan, Alexandra Corella, Henok Eyob, Kai Kessenbrock, Devon A. Lawson, Lindsey A. Marsh, Brittany Anderton, Julia Rohrberg, Ratika Kunder, Alexey V. Bazarov, Paul Yaswen, Michael T. McManus, Hope S. Rugo, Zena Werb, Andrei Goga

    Published 2016
    Get full text
    Artigo
    Save to List
    Saved in:
  17. 17
    Circulating tumor DNA and magnetic resonance imaging to predict neoadjuvant chemotherapy response and recurrence risk

    Circulating tumor DNA and magnetic resonance imaging to predict neoadjuvant chemotherapy response and recurrence risk by Mark Jesus M. Magbanua, Wen Li, Denise M. Wolf, Christina Yau, Gillian L. Hirst, Lamorna Brown Swigart, David C. Newitt, Jessica Gibbs, Amy L. Delson, Ekaterina Kalashnikova, Alexey Aleshin, Bernhard Zimmermann, A. Jo Chien, Debu Tripathy, Laura J. Esserman, Nola M. Hylton, Laura van ‘t Veer

    Published 2021
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  18. 18
    The BRCA1ness signature is associated significantly with response to PARP inhibitor treatment versus control in the I-SPY 2 randomized neoadjuvant setting

    The BRCA1ness signature is associated significantly with response to PARP inhibitor treatment versus control in the I-SPY 2 randomized neoadjuvant setting by Tesa Severson, Denise M. Wolf, Christina Yau, Justine Peeters, Diederik Wehkam, Philip C. Schouten, Suet‐Feung Chin, Ian J. Majewski, Magali Michaut, Astrid Bosma, Bernard Pereira, Tycho Bismeijer, Lodewyk F.A. Wessels, Carlos Caldas, René Bernards, Iris Simón, Annuska M. Glas, Sabine C. Linn, Laura van ‘t Veer

    Published 2017
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  19. 19
    DNA repair deficiency biomarkers and the 70-gene ultra-high risk signature as predictors of veliparib/carboplatin response in the I-SPY 2 breast cancer trial

    DNA repair deficiency biomarkers and the 70-gene ultra-high risk signature as predictors of veliparib/carboplatin response in the I-SPY 2 breast cancer trial by Denise M. Wolf, Christina Yau, Ashish Sanil, Annuska M. Glas, Emanuel F. Petricoin, Julia Wulfkuhle, Tesa Severson, Sabine C. Linn, Lamorna Brown Swigart, Gillian L. Hirst, Meredith Buxton, Angela DeMichele, Nola M. Hylton, Fraser Symmans, Douglas Yee, Melissa Paoloni, Laura J. Esserman, Don Berry, Hope S. Rugo, Olufunmilayo I. Olopade, Laura van ‘t Veer

    Published 2017
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  20. 20
    Intratumor Heterogeneity of the Estrogen Receptor and the Long-term Risk of Fatal Breast Cancer

    Intratumor Heterogeneity of the Estrogen Receptor and the Long-term Risk of Fatal Breast Cancer by Linda S. Lindström, Christina Yau, Kamila Czene, Carlie K. Thompson, Katherine A. Hoadley, Laura J. vanʼt Veer, Ronald Balassanian, John W. Bishop, Philip M. Carpenter, Yunn‐Yi Chen, Brian Datnow, Farnaz Hasteh, Gregor Krings, Fritz Lin, Yanhong Zhang, Bo Nordenskjöld, Olle Stål, Christopher C. Benz, Tommy� Fornander, Alexander D. Borowsky, Laura J. Esserman

    Published 2017
    Get full text Get full text
    Artigo
    Save to List
    Saved in:

Search Tools: